Computational Screening of Plant-Derived Natural Products against SARS-CoV-2 Variants

نویسندگان

چکیده

The present study explores the efficacy of plant-derived natural products (PDNPs) against spike glycoproteins (S-glycoprotein) SARS-CoV-2 variants using molecular docking, ADMET, dynamics (MD) simulation and density-functional theory (DFT) analysis. In all, 100 PDNPs were screened glycoprotein variants, namely alpha (B.1.1.17), beta (B.1.351), delta (B.1.617), gamma (P.1) omicron (B.1.1.529). Results showed that rutin, EGCG, hesperidin, withanolide G, rosmarinic acid, diosmetin, myricetin, epicatechin quercetin top hit compounds each variants. most active compounds, EGCG acid gave binding scores ?10.2, ?8.1, ?8.9, ?8.3 ?9.2 kcal/mol, omicron, delta, alpha, respectively. Further, stability docked complexes was confirmed by analysis descriptors (RMSD, RMSF, SASA, Rg H-bonds) in dynamic Moreover, physiochemical properties drug-likeness tested they have no toxicity or carcinogenicity may be used as druggable targets. addition, DFT revealed higher activity target proteins. This led us to conclude are good candidates S-glycoproteins vivo clinical studies needed develop them drug leads existing new currently underway our laboratory.

برای دانلود باید عضویت طلایی داشته باشید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Physical Activity and Natural Products and Minerals in the SARS-CoV-2 Pandemic: An Update

Coronavirus-disease 19 (COVID-19) has rapidly become a global public health issue, and there is a desperate need for strategies of prevention, reduction, and treatment to halt the epidemic. The coronavirus affects the immune system, and individuals with a compromised immune system, such as those with diabetes, hypertension, obesity, are more susceptible to this virus. Lifestyle-related variable...

متن کامل

SARS-CoV-2 infection: its psychiatric manifestations

Background:  The clinical presentation of SARS-CoV-2 infection was initially dominated by respiratory symptoms. However the clinical spectrum is wide and neuropsychiatric syndromes are also a source of medical concern. Our aims are to present an atypical clinical presentation of SARS-CoV-2 infection characterized by auditory hallucinations and unusual behavior and to emphasize the diversity of ...

متن کامل

Assessment of protection against SARS-CoV-2 infection by measuring antibody titer, yes or no!

Dear Editor The current epidemic of the novel Coronavirus disease 2019 (COVID-19) risen from Wuhan, China, turned into a worldwide concern because of its incubation period (2-14 days) and its high transmission rate. The first cases of the infection were reported in December 2019 in Wuhan with symptoms like pneumonia for an unknown reason. Very soon it was known as a novel kind of Coronavirus o...

متن کامل

مروری به بررسی ایمونولوژیکی SARS-Cov-2

زمینه و هدف  بیماری کووید-19 یک بیماری عفونی به‌شدت مسری می‌باشد که توسط یک کروناویروس جدید ایجاد می‌شود که می‌تواند از انسان به انسان از طریق تماس نزدیک منتقل شود. هدف از مطالعه حاضر بررسی اطلاعات جدید در زمینه ایمونولوژی کووید-19 می‌باشد. مواد و روش‌ها در مطالعه مروری حاضر، از موتورهای جستجوی Google و Google Scholar و مقالات نمایه شده در پایگاه‌های علمی معتبر بین‌المللی از جمله Pub Med، MedLi...

متن کامل

Design of a Multi-epitope Peptide Vaccine against SARS-CoV-2 based on Immunoinformatics Data

Background and purpose: In 2019, the world has witnessed the emergence of a virus that caused acute respiratory distress syndrome in human with high mortality rates (approximately 3.7%). So far, no effective treatment has been proven against COVID-19. This study aimed at designing a multi-epitope vaccine combining several T-cell and B-cell epitopes of the SARS-CoV-2. Materials and methods: Bas...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

ژورنال

عنوان ژورنال: Future Pharmacology

سال: 2022

ISSN: ['2673-9879']

DOI: https://doi.org/10.3390/futurepharmacol2040034